Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

21 trials with published results (14%)

Research Maturity

82 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.6%

10 terminated out of 151 trials

Success Rate

89.1%

+2.6% vs benchmark

Late-Stage Pipeline

13%

20 trials in Phase 3/4

Results Transparency

26%

21 of 82 completed with results

Key Signals

21 with results89% success

Data Visualizations

Phase Distribution

137Total
Not Applicable (58)
Early P 1 (2)
P 1 (12)
P 2 (45)
P 3 (12)
P 4 (8)

Trial Status

Completed82
Unknown26
Recruiting15
Terminated10
Not Yet Recruiting6
Active Not Recruiting6

Trial Success Rate

89.1%

Benchmark: 86.5%

Based on 82 completed trials

Clinical Trials (151)

Showing 20 of 20 trials
NCT07739771Not Yet RecruitingPrimary

Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.

NCT07709195Phase 2RecruitingPrimary

Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant

NCT07724444CompletedPrimary

Laser Therapy Versus Ozone Therapy for Oral Mucositis in Patients With Cancer

NCT05441813Phase 2RecruitingPrimary

Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy

NCT07672236Phase 3Recruiting

A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.

NCT01772706Not ApplicableCompleted

Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer

NCT05966194Phase 2Active Not RecruitingPrimary

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

NCT07638904CompletedPrimary

Ozone Therapy for Cancer Therapy-Related Oral Mucositis

NCT07543978Phase 3Not Yet Recruiting

Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis (RTOM)

NCT05635929Not ApplicableRecruitingPrimary

Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.

NCT07400328Phase 2RecruitingPrimary

Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients

NCT06708702Phase 2WithdrawnPrimary

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

NCT07491536Not ApplicableRecruitingPrimary

Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis

NCT06276270Not ApplicableCompletedPrimary

Multi-centre, Open-label, First-in-man Study With Mucopad HA

NCT07436650Not ApplicableRecruitingPrimary

Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT05853692Not ApplicableRecruitingPrimary

Prevention of Oral Mucositis in Head and Neck Cancer.

NCT07426198Not ApplicableCompletedPrimary

The Effect of Oral Care With Propolis in COPD Patients

NCT07387978Not ApplicableRecruitingPrimary

A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of Oral Mucositis (Oral Ulceration) in Oral Cancer Patients Undergoing Radiation Treatment

NCT07020754Phase 2Completed

Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial

NCT07372443Not ApplicableNot Yet RecruitingPrimary

Photobiomodulation in the Prevention and Management of Oral Mucositis in Children

Scroll to load more

Research Network

Activity Timeline